Print page content Print
Increase text size Decrease text size
Text Size



A potent anti-inflammatory steroid


MEDROL is indicated in dogs and cats with conditions known to be responsive to anti-inflammatory corticosteroids, including collagen, dermal, allergic, ocular, otic and musculoskeletal, as well as various chronic or recurrent diseases (ulcerative colitis and nephrosis).

Collapse All
    • With MEDROL’s enhanced potency, lower doses achieve results similar to prednisone and prednisolone, but reduce the risk of side effects such as polyuria and polydipsia.1
    • MEDROL tablets achieve peak serum levels in 1 to 2 hours, to relieve itching quickly.
    • Small, easy-to-swallow tablets are cross-scored for convenient dose adjustments. 
  • 1. McDonald RK, Langston VC. Use of corticosteroids and nonsteroidal anti-inflammatory agents. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. Diseases of the Dog and Cat. 4th ed, vol. 1. Phila, Pa: WB Saunders Co; 1995:284-293.

IMPORTANT SAFETY INFORMATION: Do not use DEPO-MEDROL in animals with tuberculosis, peptic ulcer, and Cushing’s syndrome. Use with extreme caution in pregnant animals. Watch for evidence of concurrent infection.
For more safety information, please refer to the full Prescribing Information.



Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.